Oral Rotavirus Vaccine-United States Market Status and Trend Report 2013-2023

January 2018 | 151 pages | ID: O9CD509BE95EN
MIReports Co., Limited

Abstracts

Report Summary

Oral Rotavirus Vaccine-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oral Rotavirus Vaccine industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

• Whole United States and Regional Market Size of Oral Rotavirus Vaccine 2013-2017, and development forecast 2018-2023
• Main market players of Oral Rotavirus Vaccine in United States, with company and product introduction, position in the Oral Rotavirus Vaccine market
• Market status and development trend of Oral Rotavirus Vaccine by types and applications
• Cost and profit status of Oral Rotavirus Vaccine, and marketing status
• Market growth drivers and challenges

The report segments the United States Oral Rotavirus Vaccine market as:

United States Oral Rotavirus Vaccine Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest

United States Oral Rotavirus Vaccine Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou Lamb

United States Oral Rotavirus Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Vaccination Station
Other

United States Oral Rotavirus Vaccine Market: Players Segment Analysis (Company and Product introduction, Oral Rotavirus Vaccine Sales Volume, Revenue, Price and Gross Margin):
GSK
Sanofi-Pasteur
Merck
CSL Biotherapies
LG Life Sciences
Crucell
China National Biotec Group
Hualan Biological Engineering
Sinovac Biotech
Dalian Hissen Bio-pharm

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Contents

CHAPTER 1 OVERVIEW OF ORAL ROTAVIRUS VACCINE

1.1 Definition of Oral Rotavirus Vaccine in This Report
1.2 Commercial Types of Oral Rotavirus Vaccine
  1.2.1 Rotarix
  1.2.2 RotaTeq
  1.2.3 Rotavac
  1.2.4 Rotavin-M1
  1.2.5 Lanzhou Lamb
1.3 Downstream Application of Oral Rotavirus Vaccine
  1.3.1 Hospital
  1.3.2 Vaccination Station
  1.3.3 Other
1.4 Development History of Oral Rotavirus Vaccine
1.5 Market Status and Trend of Oral Rotavirus Vaccine 2013-2023
  1.5.1 United States Oral Rotavirus Vaccine Market Status and Trend 2013-2023
  1.5.2 Regional Oral Rotavirus Vaccine Market Status and Trend 2013-2023

CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Oral Rotavirus Vaccine in United States 2013-2017
2.2 Consumption Market of Oral Rotavirus Vaccine in United States by Regions
  2.2.1 Consumption Volume of Oral Rotavirus Vaccine in United States by Regions
  2.2.2 Revenue of Oral Rotavirus Vaccine in United States by Regions
2.3 Market Analysis of Oral Rotavirus Vaccine in United States by Regions
  2.3.1 Market Analysis of Oral Rotavirus Vaccine in New England 2013-2017
  2.3.2 Market Analysis of Oral Rotavirus Vaccine in The Middle Atlantic 2013-2017
  2.3.3 Market Analysis of Oral Rotavirus Vaccine in The Midwest 2013-2017
  2.3.4 Market Analysis of Oral Rotavirus Vaccine in The West 2013-2017
  2.3.5 Market Analysis of Oral Rotavirus Vaccine in The South 2013-2017
  2.3.6 Market Analysis of Oral Rotavirus Vaccine in Southwest 2013-2017
2.4 Market Development Forecast of Oral Rotavirus Vaccine in United States 2018-2023
  2.4.1 Market Development Forecast of Oral Rotavirus Vaccine in United States 2018-2023
  2.4.2 Market Development Forecast of Oral Rotavirus Vaccine by Regions 2018-2023

CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES

3.1 Whole United States Market Status by Types
  3.1.1 Consumption Volume of Oral Rotavirus Vaccine in United States by Types
  3.1.2 Revenue of Oral Rotavirus Vaccine in United States by Types
3.2 United States Market Status by Types in Major Countries
  3.2.1 Market Status by Types in New England
  3.2.2 Market Status by Types in The Middle Atlantic
  3.2.3 Market Status by Types in The Midwest
  3.2.4 Market Status by Types in The West
  3.2.5 Market Status by Types in The South
  3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Oral Rotavirus Vaccine in United States by Types

CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Oral Rotavirus Vaccine in United States by Downstream Industry
4.2 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in New England
  4.2.2 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in The Middle Atlantic
  4.2.3 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in The Midwest
  4.2.4 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in The West
  4.2.5 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in The South
  4.2.6 Demand Volume of Oral Rotavirus Vaccine by Downstream Industry in Southwest
4.3 Market Forecast of Oral Rotavirus Vaccine in United States by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORAL ROTAVIRUS VACCINE

5.1 United States Economy Situation and Trend Overview
5.2 Oral Rotavirus Vaccine Downstream Industry Situation and Trend Overview

CHAPTER 6 ORAL ROTAVIRUS VACCINE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES

6.1 Sales Volume of Oral Rotavirus Vaccine in United States by Major Players
6.2 Revenue of Oral Rotavirus Vaccine in United States by Major Players
6.3 Basic Information of Oral Rotavirus Vaccine by Major Players
  6.3.1 Headquarters Location and Established Time of Oral Rotavirus Vaccine Major Players
  6.3.2 Employees and Revenue Level of Oral Rotavirus Vaccine Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 ORAL ROTAVIRUS VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 GSK
  7.1.1 Company profile
  7.1.2 Representative Oral Rotavirus Vaccine Product
  7.1.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of GSK
7.2 Sanofi-Pasteur
  7.2.1 Company profile
  7.2.2 Representative Oral Rotavirus Vaccine Product
  7.2.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Sanofi-Pasteur
7.3 Merck
  7.3.1 Company profile
  7.3.2 Representative Oral Rotavirus Vaccine Product
  7.3.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Merck
7.4 CSL Biotherapies
  7.4.1 Company profile
  7.4.2 Representative Oral Rotavirus Vaccine Product
  7.4.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of CSL Biotherapies
7.5 LG Life Sciences
  7.5.1 Company profile
  7.5.2 Representative Oral Rotavirus Vaccine Product
  7.5.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of LG Life Sciences
7.6 Crucell
  7.6.1 Company profile
  7.6.2 Representative Oral Rotavirus Vaccine Product
  7.6.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Crucell
7.7 China National Biotec Group
  7.7.1 Company profile
  7.7.2 Representative Oral Rotavirus Vaccine Product
  7.7.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of China National Biotec Group
7.8 Hualan Biological Engineering
  7.8.1 Company profile
  7.8.2 Representative Oral Rotavirus Vaccine Product
  7.8.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Hualan Biological Engineering
7.9 Sinovac Biotech
  7.9.1 Company profile
  7.9.2 Representative Oral Rotavirus Vaccine Product
  7.9.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Sinovac Biotech
7.10 Dalian Hissen Bio-pharm
  7.10.1 Company profile
  7.10.2 Representative Oral Rotavirus Vaccine Product
  7.10.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Dalian Hissen Bio-pharm

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL ROTAVIRUS VACCINE

8.1 Industry Chain of Oral Rotavirus Vaccine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORAL ROTAVIRUS VACCINE

9.1 Cost Structure Analysis of Oral Rotavirus Vaccine
9.2 Raw Materials Cost Analysis of Oral Rotavirus Vaccine
9.3 Labor Cost Analysis of Oral Rotavirus Vaccine
9.4 Manufacturing Expenses Analysis of Oral Rotavirus Vaccine

CHAPTER 10 MARKETING STATUS ANALYSIS OF ORAL ROTAVIRUS VACCINE

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference